Aurobindo Pharma has received final USFDA approval to launch generic Rivaroxaban 2.5mg tablets in the US, targeting a $447 ...

In addition to the final approval for the 2.5mg dosage, Aurobindo has also secured tentative approvals from the USFDA for ...